Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat
about
GLP-1 (7-36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles.Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat HeartDesign of Stable α-Helical Peptides and Thermostable Proteins in Biotechnology and Biomedicine.Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients.Synthesis and Evaluation of a Series of Long-Acting Glucagon-Like Peptide-1 (GLP-1) Pentasaccharide Conjugates for the Treatment of Type 2 Diabetes.The transcriptome of nitrofen-induced pulmonary hypoplasia in the rat model of congenital diaphragmatic hernia.Half-life extended biotherapeutics.Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.Rational design of a humanized glucagon-like peptide-1 receptor agonist antibody.Effects of liraglutide on hemodynamic parameters in patients with heart failure.Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3.Current trends and perspectives of bioactive peptides.Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
P2860
Q30411123-05C08988-C605-4624-BC61-1C6ABCA42628Q34355984-F91E5248-8B88-46B5-93AD-1B41806D0DFDQ34560277-631D4A33-59AD-4B11-9405-87087C775BB6Q35082511-8126A987-F248-4F3D-A11C-8015B0728E95Q35670896-C178C9A5-7A16-4EFF-B324-8381063DAE98Q37544873-78115758-EE15-418C-B93C-93468DC75F4EQ37581317-CF60BB68-8FF7-402E-BF08-A1E22972FC20Q38298423-97040703-01C7-4275-AE57-A336BCD145DDQ38452838-4966D7D1-7572-4B6C-B320-45DC5922D69CQ38770067-86E7B946-4BCE-41EA-99EF-ECC66DB9A63BQ39323549-AF27C315-1D3B-441E-BF55-0DC6C71AE0CAQ41629204-14E02348-6296-4DF1-B38E-3F861354CE60Q41781061-C05CA234-BDE3-43AA-9DD8-9ECBC2004929Q41852482-39733F64-030F-442D-968D-B8D1366C5431Q53834355-F2EFCA83-3A35-4E3A-A8CF-3384F0BDAC8BQ54316655-C5B31734-1E1D-4358-B4D6-55B8AE0B4FBA
P2860
Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel fusion of GLP-1 with a d ...... /reperfusion injury in the rat
@en
Novel fusion of GLP-1 with a d ...... reperfusion injury in the rat.
@nl
type
label
Novel fusion of GLP-1 with a d ...... /reperfusion injury in the rat
@en
Novel fusion of GLP-1 with a d ...... reperfusion injury in the rat.
@nl
prefLabel
Novel fusion of GLP-1 with a d ...... /reperfusion injury in the rat
@en
Novel fusion of GLP-1 with a d ...... reperfusion injury in the rat.
@nl
P2093
P2860
P356
P1476
Novel fusion of GLP-1 with a d ...... /reperfusion injury in the rat
@en
P2093
April M Barbour
Beat M Jucker
Elena DeAngelis
Gavin X Jones
John J Lepore
Karpagam Aravindhan
Larry J Jolivette
Lucy J Holt
Mathew Szapacs
Rob D Prince
P2860
P2888
P356
10.1186/1475-2840-12-148
P407
P577
2013-10-14T00:00:00Z
P5875
P6179
1017825295